Global health training in North American ophthalmology residency programs: a cross-sectional study - Nature
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
Preventable vision loss is a disproportionate global burden affecting low- and middle-income countries [1]. While contemporary frameworks highlight the pivotal role of sustained, capacity-building partnerships to address these inequities, current institutional offerings often fall short of this model [2]. Notably, prospective trainees seeking global health tracks may face limited publicly available information on structured opportunities across North America. Herein, we aimed to evaluate the documented global health training across accredited Canadian and US ophthalmology residency programs. We hypothesised that global health infrastructure remains limited and inequitably distributed. This cross-sectional study was conducted in accordance with Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines.
This article is an excerpt. To read the full content, visit the original source. Nature
Related articles
New equipment strengthens the capacity of Guinea-Bissau’s National Ophthalmology Service - WHO | Regional Office for Africa
Bioengineer.org | Viral blips during HIV therapy are common and rarely signal treatment failure, Swedish study finds - European AIDS Treatment Group
Bioengineer.org news storyFor people living with HIV, modern antiretroviral therapy can suppress the virus to levels below what standard laboratory tests can detect. Yet some patients on long-term treatment experience a curious phenomenon: a single test result showing a small, transient amount of virus in the blood, followed by an immediate return to undetectable levels. These events, known as viral blips, have puzzled clinicians and researchers for years, raising questions about whether they represent harmless statistical noise, brief bursts of viral production from hidden reservoirs, or early warnings of impending treatment failure. A new nationwide Swedish study, published in BMC Infectious Diseases, offers one of the most comprehensive answers to date. Drawing on the Swedish national InfCareHIV cohort, researchers analyzed data from 4,210 treatment-naïve adults who began antiretroviral therapy from 1 January 2007 onward, with follow-up data extracted through 30 September 2020. The median observation time was 5.5 years, with some individuals followed for as long as 13.7 years.
European Medical Journal | HIV linked to early signs of heart dysfunction - European AIDS Treatment Group
European Medical Journal news storyPeople living with HIV may experience subtle changes in heart muscle function even when conventional measures of cardiac performance remain normal, according to findings from a systematic review and meta-analysis. Researchers identified significantly impaired global longitudinal strain (GLS) among people with HIV compared with HIV-uninfected individuals, despite preserved left ventricular ejection fraction (LVEF) in both groups. The findings suggest that speckle-tracking echocardiography (STE) could provide additional information about early myocardial dysfunction in this population. Read the full news story here.
Patient-centered financial navigation assistance helps reduce financial toxicity among cancer patients - Medical Xpress
Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.
0 comments
No comments yet. Be the first to share your thoughts!